{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:19:42Z","timestamp":1762899582128,"version":"3.37.3"},"reference-count":47,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2018,7,19]],"date-time":"2018-07-19T00:00:00Z","timestamp":1531958400000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences, Inc.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European AIDS Clinical Society, Leverhulme-Royal Society Africa"},{"name":"MAC AIDS Foundation"},{"DOI":"10.13039\/100012923","name":"Royal College of Physicians of Edinburgh","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012923","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["109130\/Z\/15\/Z"],"award-info":[{"award-number":["109130\/Z\/15\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,11,1]]},"DOI":"10.1093\/jac\/dky281","type":"journal-article","created":{"date-parts":[[2018,6,25]],"date-time":"2018-06-25T15:13:19Z","timestamp":1529939599000},"page":"3148-3157","source":"Crossref","is-referenced-by-count":8,"title":["Drug resistance outcomes of long-term ART with tenofovir disoproxil fumarate in the absence of virological monitoring"],"prefix":"10.1093","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6747-9851","authenticated-orcid":false,"given":"Giovanni","family":"Villa","sequence":"first","affiliation":[{"name":"Institute of Infection & Global Health, University of Liverpool, Liverpool, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard O","family":"Phillips","sequence":"additional","affiliation":[{"name":"Department of Medicine, Kwame Nkrumah University of Science & Technology, Kumasi, Ghana"},{"name":"Komfo Anokye Teaching Hospital, Kumasi, Ghana"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colette","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Infection & Population Health, University College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander J","family":"Stockdale","sequence":"additional","affiliation":[{"name":"Institute of Infection & Global Health, University of Liverpool, Liverpool, UK"},{"name":"Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Ruggiero","sequence":"additional","affiliation":[{"name":"Institute of Infection & Global Health, University of Liverpool, Liverpool, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5639-0528","authenticated-orcid":false,"given":"Apostolos","family":"Beloukas","sequence":"additional","affiliation":[{"name":"Institute of Infection & Global Health, University of Liverpool, Liverpool, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lambert T","family":"Appiah","sequence":"additional","affiliation":[{"name":"Komfo Anokye Teaching Hospital, Kumasi, Ghana"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Chadwick","sequence":"additional","affiliation":[{"name":"Centre for Clinical Infection, James Cook University Hospital, Middlesbrough, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fred S","family":"Sarfo","sequence":"additional","affiliation":[{"name":"Komfo Anokye Teaching Hospital, Kumasi, Ghana"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Maria","family":"Geretti","sequence":"additional","affiliation":[{"name":"Institute of Infection & Global Health, University of Liverpool, Liverpool, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,7,18]]},"reference":[{"author":"Joint United Nations Programme on HIV\/AIDS (UNAIDS)","key":"key\n\t\t\t\t20181023060057660_dky281-B1"},{"author":"World Health Organization","key":"key\n\t\t\t\t20181023060057660_dky281-B2"},{"year":"2009","author":"World Health Organization","key":"key\n\t\t\t\t20181023060057660_dky281-B3"},{"key":"key\n\t\t\t\t20181023060057660_dky281-B4","first-page":"20","article-title":"Epidemiology and impact of HIV coinfection with hepatitis B and hepatitis C viruses in sub-Saharan Africa","volume":"61","author":"Matthews","year":"2014","journal-title":"J Clin Virol"},{"author":"Clinton Health Access Initiative","key":"key\n\t\t\t\t20181023060057660_dky281-B5"},{"year":"2013","author":"World Health Organization","key":"key\n\t\t\t\t20181023060057660_dky281-B6"},{"key":"key\n\t\t\t\t20181023060057660_dky281-B7","first-page":"e271","article-title":"Monitoring and switching of first-line antiretroviral therapy in adult treatment cohorts in sub-Saharan Africa: collaborative analysis","volume":"2","author":"Haas","year":"2015","journal-title":"Lancet HIV"},{"key":"key\n\t\t\t\t20181023060057660_dky281-B8","first-page":"e82724.","article-title":"Persistent difficulties in switching to second-line ART in sub-Saharan Africa\u2014a systematic review and meta-analysis","volume":"8","author":"Madec","year":"2013","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20181023060057660_dky281-B9","first-page":"e0161469","article-title":"Marginal structural models to assess delays in second-line HIV treatment initiation in South Africa","volume":"11","author":"Rohr","year":"2016","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20181023060057660_dky281-B10","first-page":"1846","article-title":"Effectiveness of protease inhibitor\/nucleos(t)ide reverse transcriptase inhibitor-based second-line antiretroviral therapy for the treatment of HIV-1 infection in sub-Saharan Africa: systematic review and meta-analysis","volume":"66","author":"Stockdale","year":"2018","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20181023060057660_dky281-B11","first-page":"758.","article-title":"From policy to practice: exploring the implementation of antiretroviral therapy access and retention policies between 2013 and 2016 in six sub-Saharan African countries","volume":"17","author":"Ambia","year":"2017","journal-title":"BMC Health Serv Res"},{"key":"key\n\t\t\t\t20181023060057660_dky281-B12","first-page":"21647.","article-title":"Effect of frequency of clinic visits and medication pick-up on antiretroviral treatment outcomes: a systematic literature review and meta-analysis","volume":"20","author":"Mutasa-Apollo","year":"2017","journal-title":"J Int AIDS Soc"},{"key":"key\n\t\t\t\t20181023060057660_dky281-B13","first-page":"1453","article-title":"Long-term virological outcomes of first-line antiretroviral therapy for HIV-1 in low- and middle-income countries: a systematic review and meta-analysis","volume":"61","author":"Boender","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20181023060057660_dky281-B14","first-page":"883","article-title":"Liver fibrosis by transient elastography and virologic outcomes after introduction of tenofovir in lamivudine-experienced adults with HIV and hepatitis B virus coinfection in Ghana","volume":"61","author":"Stockdale","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20181023060057660_dky281-B15","first-page":"149.","article-title":"Suitability of measures of self-reported medication adherence for routine clinical use: a systematic review","volume":"11","author":"Garfield","year":"2011","journal-title":"BMC Med Res Methodol"},{"key":"key\n\t\t\t\t20181023060057660_dky281-B16","first-page":"1100","article-title":"Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting","volume":"36","author":"Oyugi","year":"2014","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20181023060057660_dky281-B17","first-page":"724","article-title":"Plasma HIV-1 RNA detection below 50 copies\/mL and risk of virologic rebound in patients receiving highly active antiretroviral therapy","volume":"54","author":"Doyle","year":"2012","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20181023060057660_dky281-B18","first-page":"1033","article-title":"Detection of the NS3 Q80K polymorphism by Sanger and deep sequencing in hepatitis C virus genotype 1a strains in the UK","volume":"21","author":"Beloukas","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20181023060057660_dky281-B19","first-page":"227","article-title":"Enhanced surveillance of HIV-1 drug resistance in recently infected MSM in the UK","volume":"72","author":"Cunningham","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20181023060057660_dky281-B20","first-page":"23","article-title":"Transmission of HIV drug resistance: lessons from sensitive screening assays","volume":"28","author":"Geretti","year":"2015","journal-title":"Curr Opin Infect Dis"},{"key":"key\n\t\t\t\t20181023060057660_dky281-B21","first-page":"e45","article-title":"HIV drug resistance mutations in non-B subtypes after prolonged virological failure on NNRTI-based first-line regimens in sub-Saharan Africa","volume":"75","author":"Kityo","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20181023060057660_dky281-B22","first-page":"565","article-title":"Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study","volume":"16","author":"The TenoRes Study Group","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20181023060057660_dky281-B23","first-page":"3141","article-title":"Rates of virological suppression and drug resistance in adult HIV-1-positive patients attending primary healthcare facilities in KwaZulu-Natal, South Africa","volume":"72","author":"Hunt","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20181023060057660_dky281-B24","first-page":"2918","article-title":"Accumulation of HIV-1 drug resistance after continued virological failure on first-line ART in adults and children in sub-Saharan Africa","volume":"71","author":"Boender","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20181023060057660_dky281-B25","first-page":"1159","article-title":"High viral load and multidrug resistance due to late switch to second-line regimens could be a major obstacle to reach the 90-90-90 UNAIDS objectives in sub-Saharan Africa","volume":"32","author":"Guichet","year":"2016","journal-title":"AIDS Res Hum Retroviruses"},{"key":"key\n\t\t\t\t20181023060057660_dky281-B26","first-page":"23","article-title":"Unnecessary antiretroviral treatment switches and accumulation of HIV resistance mutations; two arguments for viral load monitoring in Africa","volume":"58","author":"Sigaloff","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20181023060057660_dky281-B27","first-page":"377","article-title":"Accumulation of drug resistance and loss of therapeutic options precede commonly used criteria for treatment failure in HIV-1 subtype-C-infected patients","volume":"17","author":"Barth","year":"2012","journal-title":"Antivir Ther"},{"key":"key\n\t\t\t\t20181023060057660_dky281-B28","first-page":"1660","article-title":"Patterns of HIV-1 drug resistance after first-line antiretroviral therapy (ART) failure in 6 sub-Saharan African countries: implications for second-line ART strategies","volume":"54","author":"Hamers","year":"2012","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20181023060057660_dky281-B29","first-page":"841","article-title":"Antiretroviral resistance after first-line antiretroviral therapy failure in diverse HIV-1 subtypes in the SECOND-LINE study","volume":"32","author":"Lam","year":"2016","journal-title":"AIDS Res Hum Retroviruses"},{"key":"key\n\t\t\t\t20181023060057660_dky281-B30","first-page":"605.","article-title":"Accumulation of HIV-1 drug resistance in patients on a standard thymidine analogue-based first line antiretroviral therapy after virological failure: implications for the activity of next-line regimens from a longitudinal study in Mozambique","volume":"17","author":"De Luca","year":"2017","journal-title":"BMC Infect Dis"},{"key":"key\n\t\t\t\t20181023060057660_dky281-B31","first-page":"225","article-title":"Mutational correlates of virological failure in individuals receiving a WHO-recommended tenofovir-containing first-line regimen: an international collaboration","volume":"18","author":"Rhee","year":"2017","journal-title":"EBioMedicine"},{"key":"key\n\t\t\t\t20181023060057660_dky281-B32","first-page":"222","article-title":"Replication-dependent 65R\u2192K reversion in human immunodeficiency virus type 1 reverse transcriptase double mutant K65R + L74V","volume":"321","author":"Sharma","year":"2004","journal-title":"Virology"},{"key":"key\n\t\t\t\t20181023060057660_dky281-B33","first-page":"33.","article-title":"A Leu to Ile but not Leu to Val change at HIV-1 reverse transcriptase codon 74 in the background of K65R mutation leads to an increased processivity of K65R+L74I enzyme and a replication competent virus","volume":"8","author":"Chunduri","year":"2011","journal-title":"Virology J"},{"key":"key\n\t\t\t\t20181023060057660_dky281-B34","first-page":"95","article-title":"Antiretroviral combinations implicated in emergence of the L74I and L74V resistance mutations in HIV-1-infected patients","volume":"23","author":"Wirden","year":"2009","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20181023060057660_dky281-B35","article-title":"The transition to dolutegravir and other new antiretrovirals in low- and middle-income countries\u2014what are the issues?","author":"Vitoria","year":"2018","journal-title":"AIDS"},{"year":"2017","author":"World Health Organization","key":"key\n\t\t\t\t20181023060057660_dky281-B36"},{"key":"key\n\t\t\t\t20181023060057660_dky281-B37","first-page":"515","article-title":"Saving up for the future: HAART stock-outs as a contributor to treatment non-compliance among HIV-positive patients in Kumasi, Ghana","volume":"82","author":"Moriarty","year":"2016","journal-title":"Ann Global Health"},{"key":"key\n\t\t\t\t20181023060057660_dky281-B38","first-page":"83","article-title":"Structural barriers to ART adherence in Southern Africa: challenges and potential ways forward","volume":"6","author":"Kagee","year":"2011","journal-title":"Glob Public Health"},{"key":"key\n\t\t\t\t20181023060057660_dky281-B39","first-page":"e13414.","article-title":"Impact of drug stock-outs on death and retention to care among HIV-infected patients on combination antiretroviral therapy in Abidjan, Cote d\u2019Ivoire","volume":"5","author":"Pasquet","year":"2010","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20181023060057660_dky281-B40","first-page":"359","article-title":"Community-based ART programs: sustaining adherence and follow-up","volume":"13","author":"Mukherjee","year":"2016","journal-title":"Curr HIV\/AIDS Rep"},{"key":"key\n\t\t\t\t20181023060057660_dky281-B41","first-page":"241","article-title":"Community-based interventions to improve and sustain antiretroviral therapy adherence, retention in HIV care and clinical outcomes in low- and middle-income countries for achieving the UNAIDS 90-90-90 targets","volume":"13","author":"Nachega","year":"2016","journal-title":"Curr HIV\/AIDS Rep"},{"key":"key\n\t\t\t\t20181023060057660_dky281-B42","first-page":"e1002463","article-title":"Treatment eligibility and retention in clinical HIV care: a regression discontinuity study in South Africa","volume":"14","author":"Bor","year":"2017","journal-title":"PLoS Med"},{"key":"key\n\t\t\t\t20181023060057660_dky281-B43","first-page":"e69266.","article-title":"Sensitive assessment of the virologic outcomes of stopping and restarting non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy","volume":"8","author":"Geretti","year":"2013","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20181023060057660_dky281-B44","first-page":"188","article-title":"Effect of HIV-1 low-level viremia during antiretroviral therapy on treatment outcomes in WHO-guided South African treatment programmes: a multicentre cohort study","volume":"18","author":"Hermans","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20181023060057660_dky281-B45","first-page":"e341","article-title":"Nucleoside reverse-transcriptase inhibitor cross-resistance and outcomes from second-line antiretroviral therapy in the public health approach: an observational analysis within the randomised, open-label, EARNEST trial","volume":"4","author":"Paton","year":"2017","journal-title":"Lancet HIV"},{"key":"key\n\t\t\t\t20181023060057660_dky281-B46","first-page":"837","article-title":"Genotypic and phenotypic predictors of the magnitude of response to tenofovir disoproxil fumarate treatment in antiretroviral-experienced patients","volume":"189","author":"Miller","year":"2004","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20181023060057660_dky281-B47","first-page":"19164.","article-title":"Increasing the use of second-line therapy is a cost-effective approach to prevent the spread of drug-resistant HIV: a mathematical modelling study","volume":"17","author":"Nichols","year":"2014","journal-title":"J Int AIDS Soc"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/73\/11\/3148\/26144601\/dky281.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,25]],"date-time":"2018-10-25T00:37:28Z","timestamp":1540427848000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/73\/11\/3148\/5055837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,18]]},"references-count":47,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2018,7,18]]},"published-print":{"date-parts":[[2018,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dky281","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"type":"print","value":"0305-7453"},{"type":"electronic","value":"1460-2091"}],"subject":[],"published-other":{"date-parts":[[2018,11]]},"published":{"date-parts":[[2018,7,18]]}}}